Apple (NSDQ:AAPL) is reportedly conducting internal research into whether its iPhone and Apple Watch could be used to monitor drug dosage and wellness data for patients suffering from Parkinson’s disease. The company hopes to show the effectiveness of mobile monitoring, sources told Fast Company. Patients who suffer from Parkinson’s disease may only visit their doctor at 6-month intervals, which […]
mHealth (Mobile Health)
Cellnovo files 510(k) for connected diabetes management system
Cellnovo (EPA:CLNV) said today that it has filed for 510(k) clearance from the FDA for its diabetes management system. Paris-based Cellnovo touts its system as the 1st mobile, connected diabetes management system. Tubeless and compact, the company’s insulin pump has a mobile touchscreen controller with an integrated blood glucose meter. Data from insulin injections and blood-glucose levels are […]
Smiths Medical debuts drug pump software
Smiths Group (LON:SMIN) Smiths Medical division today launched an updated version of its PharmGuard interoperability software for its Medfusion 4000 wireless syringe pumps. The new version features bi-directional integration with any IHE compatible electronic medical record system, the company said. Smart pump programming allows a clinician order to be sent directly to the Medfusion pump, […]
Propeller wins FDA nod for connected GSK Ellipta inhaler
Propeller Health said today that it won 510(k) clearance from the FDA to market its Propeller platform with GlaxoSmithKline‘s (NYSE:GSK) Ellipta inhaler. A sensor for the dry powder inhaler was built as a part of a 1 year-long development and R&D collaboration between Propeller and GSK. This marks the 8th clearance for Propeller’s connected inhaler platform. […]
Litmus Health looks to bring wearables to drug development
Litmus Health said yesterday that it launched its clinical data science platform into public beta. The company hopes to use big data from wearables and connected devices to help inform endpoints for Phase I & II clinical trials. The goal of its platform, according to Litmus, is to get pharmaceuticals to market faster by putting […]
CERN researcher’s fertility app is as good as oral contraceptives, condoms
Natural Cycles, the fertility app developed by former CERN particle physicist Elina Berglund, is reportedly as effective at preventing pregnancy as oral contraceptives or condoms, boasting a 99.5% efficacy rate. Berglund began working on the app while she was still at the particle physics laboratory in Geneva, she told Wired. “I wanted to give my […]
QuiO raises $1m for smart injection device
QuiO said last week that it closed a $1.05 million seed round led by undisclosed investors to finish developing its smart injection device, prep for pilot studies and an FDA 510(k) submission. The New York-based company is developing a smart injection device and software to monitor patient adherence to clinical trial and daily regimens. Average […]
Changing healthcare & clinical trials with patient monitoring tech
Patient monitoring can be challenging, often relying on patients to self-report symptoms or describe how they’re feeling. But technology is changing that, making it easier for researchers to monitor patient adherence to a trial’s regimen and for doctors to personalize a patient’s treatment. At the FierceBiotech Drug Development Forum in Boston today, a panel took up the […]
Chrono Therapeutics closes $48m Series B for smart nicotine patch
Hayward, Calif.-based startup Chrono Therapeutics reportedly raised $47.6m in a Series B round, led by Kaiser Permanente Ventures. The money, Chrono CEO Alan Levy told Forbes, is to fund clinical trials of a transdermal smoking cessation patch. The company is preparing for a large, Phase II efficacy study of the technology. Unlike normal nicotine patches, Chrono said […]
Boehringer Ingelheim, Qualcomm team on connected inhaler
Boehringer Ingelheim Pharmaceuticals and Qualcomm (NSDQ:QCOM) subsidiary Qualcomm Life yesterday said they’re partnering to create an inhaler that can track user information, hoping to improve outcomes for chronic obstructive pulmonary disease. Boehringer tapped Qualcomm to create a low-power, disposable module for Boehringer’s Respimat inhaler, using Qualcomm’s 2net Design platform to build a wireless communication component into the inhaler. The […]